Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

It was observed that there was a statistically significant difference in the frequency of detectable and undetectable IL-4 levels between cases and controls with respect to all the subgroups of IgE levels, age, gender, dwelling, smoking status, eosinophil count and vitamin D levels (P < 0.01) (Table 3).Correlation of various clinico-pathological characteristics of cases and controls with serum IL-4 levelsVariablesCasesControlsOR (95%CI)P ValueNumber (n)Un (%)Dn (%)Number (n)Un (%)Dn (%)n = 528120 (22.7)408 (77.3)n = 610493 (80.9)117 (19.1)14.3 (10.7 to 19.0) < 0.0001Age < 40414 (78.4)102312459 (75.0)3738613.2 (9.5 to 18.3) < 0.0001 > 40114 (21.6)1896151 (25.0)1203120.6 (10.8 to 39.1) < 0.0001Gender Male210 (39.8)36174255 (41.8)2055019.8 (13.3 to 31.8) < 0.0001 Female318 (60.2)84234355 (58.2)2886711.9 (8.3 to 17.2) < 0.0001Dwelling Urban240 (45.5)48192281 (46.1)2216014.7 (9.6 to 22.5) < 0.0001 Rural288 (54.5)72216329 (44.9)2725714.3 (9.6 to 21.1) < 0.0001Smoking status Smokers63 (12.0)1215138 (6.2)320667.1 (23.4 to 92.0) < 0.0001 Non-smokers165 (31.2)42123345 (56.5)187401.36 (8.3 to 22.3) < 0.0001 Passive smokers300 (56.8)66234227 (37.3)2747113.6 (9.3 to 19.9) < 0.0001IgE levels Normal03 (0.6)0003487 (79.8)4058219.5 (2.1 to 77.2) < 0.0001 Elevated525 (99.4)120405123 (20.2)88358.4 (5.4 to 13.1) < 0.0001Eosinophil count Normal297 (56.3)75222519 (85.1)41910012.4 (8.8 to 17.4) < 0.0001 Elevated231 (43.7)4518691 (14.9)741717.9 (9.6 to 33.4) < 0.0001Vitamin D levels (ng/ml) Deficient (< 20)345 (65.3)93252503 (82.4)4089511.6 (8.3 to 16.1) < 0.0001 Insufficient (20 to 30)111 (21.0)159649 (8.0)400928.4 (11.5 to 70.3) < 0.0001 Sufficient (31 to 100)72 (13.7)126058 (9.6)451317.3 (7.2 to 41.5) < 0.0001ESR1.0 (0.6 to 1.7)0.7 Normal414 (78.4)93321 Elevated114 (21.6)2787PFT0.7 (0.4 to 1.09)0.1 Normal324 (61.4)81243 Abnormal204 (38.6)39165SPT0.7 HDM72 (13.6)1557 Pollens39 (7.3)0930 HDM/pollens114 (21.6)2193 HDM/pollens/fungi/AE66 (12.5)2442 HDM/pollens/few foods/AE225 (42.6)4877 Negative12 (2.2)0309Socio economic status1.6 (0.98 to 2.5)0.06 Good150 (28.4)27123 Average336 (63.6)87249 Poor42 (8.0)0636Seasonal/year round Year round387 (73.3)99288 Seasonal141 (26.7)211200.5 (0.3 to 0.8)0.009Peak time1.3 (0.9 to 2.0)0.1 Morning255 (48.2)512041.3 (0.5 to 3.5)0.3 Evening249 (47.1)63186 Both24 (4.5)0618Family history1.1 (0.7 to 1.8)0.6 Yes393 (74.5)87306 No135 (25.5)33102Triggers0.2 Dust174 (32.9)42132 Dust/irritant210 (39.7)51159 Temperature12 (2.3)039 Irritants132 (25.0)24108Co-morbidity Diabetes24 (4.5)0321 Hypertension27 (5.1)0324 Diabetes/hypertension/obesity16 (2.7)0016 Hypothyroidism51 (9.6)1536 PCOD21 (3.9)0318 Nil389 (73.6)962930.02Collateral diseases0.3 Drug allergy60 (11.5)1248 Migraine120 (22.7)3090 Food allergy90 (17.0)1575 Migraine/food allergy09 (1.7)0603 Migraine/drug allergy06 (1.1)0006 Nil243 (46.0)57186Diagnosis0.03 AR/BA210 (39.7)45165 AR/AD57 (10.8)0651 AR/CU36 (6.8)0927 AR/BA/AD120 (22.7)2793 AR/BA/CU75 (14.2)2154 AR/BA/conjunctivitis12 (2.3)0606 BA/CU18 (3.4)0612IL Interleukin, U undetectable, D detectable, IgE immunoglobulin E, GAD general anxiety disorder, MDD major depressive disorder, ESR eosinophil sedimentation rate, LSCS lower segment caesarian section, TSH thyroid stimulating hormone, PFT pulmonary function test, HDM house dust mite, AE animal epithelia, AR atopic rhinitis, BA bronchial asthma, AD topic dermatitis, CU chronic urticaria0.7 pg/ml is the minimum value below which the interleukin levels (IL-4) were treated as undetectable

Source: Serum IL-4 levels and their association with demographic and clinicopathological characteristics of cases and controls. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Atopy in Kashmir-validation from a case control study with respect to IgE and Interleukin genes

Source: Article title.

Patients were considered atopic if at least they had one positive skin test result.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Atopy in Kashmir-validation from a case control study with respect to IgE and Interleukin genes

Case-control study · Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology · 2021

Original publication title

Atopy in Kashmir-validation from a case control study with respect to IgE and Interleukin genes

Taha Ashraf Qurashi; Aaliya Shah; Gulzar Ahmad Bhat; Mosin Saleem Khan; Roohi Rasool; Syed Mudassar

© The Author(s) 2021

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our study suggests that increased IgE levels and in association with variant forms of IL-4 and IL-13 genes are significantly associated with different types of allergies in study population.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Increased levels of serum Immunoglobulin-E (IgE) and different genetic variants of cytokines are common biochemical manifestation in Allergy. The current study was aimed to study the association of IgE and different variants of Interleukin-4 (IL-4), and Interleukin-13 (IL-13) genes with different kind of allergies.

Source: Objectives

Abstract: What methods does the paper describe?

A pre-tested questionnaire was used to collect all the dietary, life style and clinical details by a trained staff. A blood sample of 2 ml each was collected in coagulated and anti-coagulated vials. DNA and serum samples were extracted and stored until further use. Serum IgE were estimated by ELISA while as the genotypic analysis was done by PCR: RFLP methods.

Source: Methods

Abstract: Results

Statistically a significant difference of serum IgE levels were observed among cases and controls (P < 0.05). The observed significant difference of serum IgE levels were retained among subjects who also harboured variant genotypes of IL-4 and IL-13 genes (P < 0.05). Additionally, the above genetic variants significantly modified the risk of allergy when stratification was done based on various clinical characteristics.

Source: Results

Abstract: Conclusion

Our study suggests that increased IgE levels and in association with variant forms of IL-4 and IL-13 genes are significantly associated with different types of allergies in study population.

Source: Conclusion
Authors’ abstract

Objectives

Increased levels of serum Immunoglobulin-E (IgE) and different genetic variants of cytokines are common biochemical manifestation in Allergy. The current study was aimed to study the association of IgE and different variants of Interleukin-4 (IL-4), and Interleukin-13 (IL-13) genes with different kind of allergies.

Methods

A pre-tested questionnaire was used to collect all the dietary, life style and clinical details by a trained staff. A blood sample of 2 ml each was collected in coagulated and anti-coagulated vials. DNA and serum samples were extracted and stored until further use. Serum IgE were estimated by ELISA while as the genotypic analysis was done by PCR: RFLP methods.

Results

Statistically a significant difference of serum IgE levels were observed among cases and controls (P < 0.05). The observed significant difference of serum IgE levels were retained among subjects who also harboured variant genotypes of IL-4 and IL-13 genes (P < 0.05). Additionally, the above genetic variants significantly modified the risk of allergy when stratification was done based on various clinical characteristics.

Conclusion

Our study suggests that increased IgE levels and in association with variant forms of IL-4 and IL-13 genes are significantly associated with different types of allergies in study population.

Publication and source details

Original title: Atopy in Kashmir-validation from a case control study with respect to IgE and Interleukin genes

Taha Ashraf Qurashi; Aaliya Shah; Gulzar Ahmad Bhat; Mosin Saleem Khan; Roohi Rasool; Syed Mudassar

Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology · 2021

© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T11:02:53.591005+00:00

DOI: 10.1186/s13223-021-00623-5 · PMC8609820